242 filings
Page 4 of 13
8-K
k7yps w6051zck
27 Jul 21
Termination of a Material Definitive Agreement
5:04pm
8-K
y88p49metzcao93n6l
6 Jul 21
Other Events
4:10pm
8-K
7p14jo j1u0wdb63zgs
2 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
8-K
z3mo56
5 May 21
CytoSorbents Reports First Quarter 2021 Financial and Operational Results
6:03am
8-K
hhpq8rf12t3q msiz
20 Apr 21
U.S. FDA Approves CytoSorbents to Initiate U.S. STAR-T Trial For Ticagrelor Removal During Cardiothoracic Surgery
4:30pm
8-K
guqavbpq df6bf7ab
15 Apr 21
Departure of Directors or Certain Officers
12:00am
8-K
aa2znvb4
8 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:50pm
8-K
bjfvaczsg6q06bsezu
31 Mar 21
CytoSorbents Announces Lease of New Global Headquarters in Princeton, New Jersey
4:21pm
8-K
xlcroo xf
17 Mar 21
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for U.S. Trial on Ticagrelor Removal During Cardiothoracic Surgery
4:30pm
8-K
qaax dojpr1k0
9 Mar 21
CytoSorbents Announces 2020 Financial and Operational Results
4:30pm
8-K
izn4i
18 Feb 21
Other Events
4:30pm
8-K
yizr 1qxd5
12 Jan 21
CytoSorbents Reports Preliminary Fourth Quarter and Full Year 2020 Revenue
4:30pm
8-K
o86se81epm3emvalaf37
10 Dec 20
Entry into a Material Definitive Agreement
4:30pm
8-K
sypf4z6ltr4vkb
5 Nov 20
CytoSorbents Reports Record Third Quarter 2020 Financial Results
12:00am
8-K
ykdmydd u7nz
4 Aug 20
CytoSorbents Reports Record Second Quarter 2020 Financial Results
5:01pm
8-K
atgew
24 Jul 20
Other Events
4:08pm
8-K
a3qq8b 41wrns
22 Jul 20
CytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common Stock
5:26pm
8-K
t00zw595h
21 Jul 20
Other Events
9:30pm
8-K
mozh86fa7ops2 ig
20 Jul 20
CytoSorbents Provides Preliminary Q2 2020 Financial Results and Corporate Update
4:49pm
8-K
ldupx7x
26 Jun 20
Other Events
12:00am